Article
Reovirus sensitizes microsatellite stable colorectal cancer to anti-PD-1 treatment via cross-talk in innate and adaptive immune systems
2021-09-04
Abstract excerpt
<h4>Background</h4> Microsatellite stable (MSS) colorectal cancer (CRC) represents ~ 85% of all CRCs. These tumors are poorly immunogenic and largely resistant to immunotherapy, necessitating a need to develop new immune enhancing strategies. Oncolytic reovirus has a high propensity to replicate in KRAS mutant tumors which account for ~ 50% of MSS CRCs. Current study explores the ability of reovirus to potenti...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 26636ed0-f5c6-5b26-b1f3-1b3fa023dd00
- DOI
- 10.1101/2021.09.03.458915
